Pfizer Inc and its group companies filed a petition in a US court against Aurobindo Pharma Ltd and Dr Reddy's Laboratories alleging that the Indian drug makers were planning separately to come out with generic versions of its blockbuster multi-billion dollar drug Ibrance (palbociclib) before expiration of its patent.from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/2IyHTBN
No comments:
Post a Comment